AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 8th, 2025 • Lb Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 8th, 2025 Company Industry JurisdictionTHIS AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), is made as of September 4, 2025 (the “Effective Date”), by and between LB Pharmaceuticals Inc, a Delaware Corporation, (the “Company”) and Anna Eramo, MD, an individual residing at *** (the “Executive”). The Company and Executive are each a “Party,” and together, the “Parties.”
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 8th, 2025 • Lb Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 8th, 2025 Company Industry JurisdictionTHIS AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), is made as of September 3, 2025 (the “Effective Date”), by and between LB Pharmaceuticals Inc, a Delaware Corporation, (the “Company”) and Marc Panoff, an individual residing at *** (the “Executive”). The Company and Executive are each a “Party,” and together, the “Parties.”